One thousand seventy-eight autologous IVF cycles in women 45 years and older: the largest single-center cohort to date
The purpose of this study was to determine IVF outcomes in women 45 years and older using autologous oocytes.
This is a retrospective cohort study reviewing all IVF cycles in women ≥ 45 years old from January 1995 to June 2015 that were conducted at one academic medical center. One thousand seventy-eight fresh, autologous IVF cycles met inclusion criteria. PGD/S, natural IVF, and donor egg cycles were excluded. Outcomes were analyzed for the different age groups (age 45, n = 773; age 46, n = 221; age 47, n = 57; age 48, n = 22; age 49, n = 5). Primary outcome measures included IVF cycle characteristics, total pregnancy loss, clinical pregnancy, and live birth rates, and were stratified according to patient age.
Mean age of patients in the study cohort was 45.4 ± 0.72. 11.7% of patients did not start due to an elevated FSH or cyst and 28.5% of patients were canceled prior to oocyte retrieval. The overall pregnancy rate per transfer was 18.7% (117/626), of which 82.1% ended in a pregnancy loss. The overall clinical pregnancy and live birth rates per transfer were 9.6 and 3.4%, respectively, which did not differ between age groups. Per cycle start women aged 45 had significantly higher positive pregnancy rates compared to women aged 46 and 47 (14.1 vs. 8.6 vs. 5.9%, p = 0.04). For women 45 years old, the live birth rate was 2.9% per cycle start and was 4.4% per embryo transfer. Of the 21 live births, 20 were in women aged 45 and one live birth was in a 46-year-old woman. There were no live births in any patient with ≤ 4 oocytes retrieved.
Autologous IVF in women aged 45 with acceptable ovarian reserve is not futile; however, it does carry very low prognosis. Patients aged 46 and older should be counseled appropriately that a live birth seems highly unlikely.
KeywordsART Advanced reproductive age Advanced maternal age Autologous IVF Age 45 and older
Compliance with ethical standards
This study was approved by the Weill Cornell Medical College Institutional Review Board.
Conflict of interest
The authors declare that they have no conflict of interest.
For this type of study, formal consent is not required.
- 1.National Vital Statistics Reports. National Vital Statistics Reports. 2016;1–70.Google Scholar
- 2.National Center for Health Statistics. Births in the United States, 2015; 2016: 1–8.Google Scholar
- 5.Franasiak JM, Forman EJ, Hong KH, Werner MD, Upham KM, Treff NR, et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril. 2014;101:656–663.e1.CrossRefPubMedGoogle Scholar
- 7.Female age-related fertility decline. Committee Opinion No. 589. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2014;123:719–21.Google Scholar
- 14.Reichman D, Rosenwaks Z. GnRH antagonist-based protocols for in vitro fertilization. In: Rosenwaks Z, Wassarman P, editors. Human fertility. Methods in molecular biology, vol 1154. New York: Humana Press; 2014. p. 289–304.Google Scholar
- 23.Rubio C, Bellver J, Rodrigo L, Bosch E, Mercader A, Vidal C, et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertil Steril. 2013;99:1400–7.CrossRefPubMedGoogle Scholar
- 28.Twisk M, Mastenbroek S, Van Wely M, Heineman MJ, Van der Veen F, Repping S. Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection (review). Cochrane Database Syst Rev. 2006.Google Scholar